DNA X, Inc. (SONM) stock
SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
$2.17−0.21 (-8.82%)
Close on Nov 13, 2026Market cap $3.23MP/E –Yield –
DNA X r&d expenses
Research and development expenses are spending on new products and technology.
DNA X's R&D Expenses for the twelve months ending Sep 30, 2025 was $15.23M, up 473.9% year over year. For fiscal 2024 it was $14.24M, up 703.3% from the year before. The highest annual figure on record is $26.06M in fiscal 2019.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $14.24M | +703.3% |
| FY2023 | Dec 31, 2023 | $1.77M | -77.8% |
| FY2022 | Dec 31, 2022 | $7.97M | -54.9% |
| FY2021 | Dec 31, 2021 | $17.70M | +9.1% |
| FY2020 | Dec 31, 2020 | $16.22M | -37.8% |
| FY2019 | Dec 31, 2019 | $26.06M | +12.1% |
| FY2018 | Dec 31, 2018 | $23.25M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $181.00K | -74.7% |
| Q2 FY2025 | Jun 30, 2025 | $909.00K | +63.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.63M | +258.1% |
| Q4 FY2024 | Dec 31, 2024 | $12.51M | +1250.6% |
| Q3 FY2024 | Sep 30, 2024 | $715.00K | -3.5% |
| Q2 FY2024 | Jun 30, 2024 | $557.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $456.00K | +334.3% |
| Q4 FY2023 | Dec 31, 2023 | $926.00K | -24.0% |
| Q3 FY2023 | Sep 30, 2023 | $741.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $105.00K | -97.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.22M | -68.5% |
| Q3 FY2022 | Sep 30, 2022 | -$135.00K | -102.5% |
| Q2 FY2022 | Jun 30, 2022 | $2.72M | -25.9% |
| Q1 FY2022 | Mar 31, 2022 | $4.17M | -10.6% |
| Q4 FY2021 | Dec 31, 2021 | $3.87M | -31.3% |
| Q3 FY2021 | Sep 30, 2021 | $5.49M | +39.5% |
| Q2 FY2021 | Jun 30, 2021 | $3.67M | -27.6% |
| Q1 FY2021 | Mar 31, 2021 | $4.66M | -29.9% |
| Q4 FY2020 | Dec 31, 2020 | $5.64M | -23.7% |
| Q1 FY2020 | Mar 31, 2020 | $3.94M | -43.5% |
| Q4 FY2019 | Dec 31, 2019 | $5.07M | -21.8% |
| Q3 FY2019 | Sep 30, 2019 | $6.65M | +10.9% |
| Q2 FY2019 | Jun 30, 2019 | $7.38M | +31.3% |
| Q1 FY2019 | Mar 31, 2019 | $6.96M | +35.4% |
| Q4 FY2018 | Dec 31, 2018 | $6.48M | – |
| Q3 FY2018 | Sep 30, 2018 | $6.00M | – |
| Q2 FY2018 | Jun 30, 2018 | $5.63M | – |
| Q1 FY2018 | Mar 31, 2018 | $5.14M | – |
See a number that looks wrong?